Sign in →

Epic Code LAB3530 A1 Antigen

Important Note

Specimens for Blood Bank must have 2 signatures on the specimen written in ink that is resistant to smearing. See Collection Information for more info.

Test Name Alias

A1 Ag | 7057

Interface Order Alias

11782

Quick Collect

BB 2 SIGNERS

Icons & Photos

6 mL Pink Top (EDTA) 3 mL Lavender Top (EDTA)

Specimen Requirements

Specimen Collection: Blood

 

Container(s): 6 mL Pink Top (EDTA) or 3 mL Lavender Top (EDTA)

Preferred Volume to Collect: 6.0 mL

Minimum Volume to Collect: 1.0 mL

Neonate Volume to Collect: 0.5 mL

Capillary Collect Acceptable? Yes

Collection Instructions:

  • Gently invert EDTA tube(s) 8 - 10 times after collection.
  • BB 2 Signers: Specimens for Blood Bank must have 2 signatures on the specimen written in ink that is resistant to smearing:
    • User ID's or initials of collectors/witnesses
      • Outpatient collection: The patient may serve as witness and initial the tube label.
      • Policytech reference #6476
    • Specimen must be labeled in the presence of the patient with:
      • Patient's first and last name
      • Unique identification number (MRN)
      • Date of collection
    • If there is any question as to the validity of the specimen identification or an inconsistency between current and previous results, a new specimen must be collected.

 

Processing Instructions (Laboratory, Outpatient or Off-site collection)

Processed Specimen: Whole Blood EDTA

Centrifuge/Spin: No

Aliquot: No

Transport Temperature: Ambient or Refrigerate

Specimen Stability

Ambient: 24 hours

Refrigerate: 10 days

Laboratory Retention: 10 days

Test Frequency

Available 24 hours, usual TAT 1 day

Reference Range

Not available

Performing Department

Blood Bank

Performing Department Laboratory Location

Corewell Health Big Rapids Laboratory, Big Rapids, MI
Corewell Health Blodgett Laboratory, Grand Rapids, MI
Corewell Health Butterworth Laboratory. Grand Rapids, MI

Methodology

Tube Technique

CPT

86905

Epic Test ID

1230100280

Reviewed Date

2/1/2022